Inhaled Molgramostim Improved Exercise Capacity
Phase 3 clinical trial data shows improvements in walking distance and duration for patients with autoimmune pulmonary alveolar proteinosis treated with inhaled molgramostim.
Tag: pulmonary alveolar proteinosis
Inhaled Molgramostim Improved Exercise Capacity
Phase 3 clinical trial data shows improvements in walking distance and duration for patients with autoimmune pulmonary alveolar proteinosis treated with inhaled molgramostim.
Read More
Infection Risk in Pulmonary Alveolar Proteinosis
Patients with Pulmonary Alveolar Proteinosis are unable to mount an effective defense against microbes due to impairment of neutrophils.
Read More